세계의 세포 용해/세포 분획 시장 규모 : 세포 유형별, 최종 사용자별, 제품별, 지역별, 범위 및 예측
Global Cell Lysis/Cell Fractionation Market Size By Type Of Cell, By End User, By Product, By Geographic Scope And Forecast
상품코드:1624410
리서치사:Verified Market Research
발행일:2024년 09월
페이지 정보:영문 202 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세포 용해/세포 분획 시장 규모 및 예측
세포 용해/세포 분획 시장 규모는 2023년에 45억 5,000만 달러로 평가되었으며, 2024년부터 2030년까지 연평균 7.2% 성장할 것으로 예상됩니다. 2030년에는 63억 달러에 달할 것으로 예측되고 있습니다. 다양한 질병의 유병률이 지속적으로 증가하고 새로운 치료법에 대한 수요가 증가함에 따라 예측 기간을 동안 시장 확대를 촉진할 것으로 예측됩니다. 또한 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.
글로벌 세포 용해/세포 분획 시장 정의
세포 용해/세포 분획은 세포 생물학에서 세포와 그 성분을 열고 분리하는 데 사용되는 관련 기술입니다. 세포를 방출하는 것을 말합니다. 세포의 개방은 화학적, 기계적 또는 효소적으로 수행됩니다. 여러 연구 응용 분야에서 필수적인 단계입니다.
세포 분획은 용해 후 세포의 다양한 성분을 분리하는 것입니다.이 과정은 밀도 구배 원심 분리, 차등 원심 분리 및 세포 내 또는 특정 유기체를 분리하는 방법으로 수행됩니다. 얻은 물질의 분획은 추가 분석에 사용할 수 있습니다.
세계의 세포 용해/세포 분획 시장 개요
인구 중 개인 맞춤형 의료에 대한 수요가 높아지고 있는 것이 시장의 주요 촉진요인입니다. 효율적인 임상시험과 같은 몇 가지 이점을 제공합니다. 맞춤형 의료는 의료 전문가가 환자에게 맞는 치료를 제공할 수 있습니다. 치료는 라이프 스타일, 특정 유전적 체질 및 기타 요인에 따라 수행됩니다.이러한 요인은 치료 결과를 개선하고 약물의 부작용 위험을 줄일 수 있습니다. 세포용해는 환자의 치료나 진단과 관련된 특정 분자나 세포 유형을 추출,분리하는 맞춤형 의료에 응용되고 있습니다.
생명과학 연구를 위한 공공기관 및 민간기관에 의한 투자 증가는 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다. 그리고 그 중 정부가 1,700만 파운드를 지원할 예정입니다. 2억 6,000만 파운드는 생명과학 제조 프로젝트, 환경에 미치는 영향 최소화, 건강 회복력 강화, 혁신 구축을 위한 민간 투자를 통해 제공되며 국가 성장에 기여할 것입니다. 500개 이상의 일자리가 창출되어 국가 경제를 지원할 것으로 기대됩니다.
또한 암, 당뇨병, 심혈관 질환, 관절염 등 만성 질환의 유병률 증가는 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다. 세포 용해 및 분획은 만성 질환을 진단하는 데 사용되는 핵심 단계입니다. 예를 들어, 류마티스 관절염과 같은자가면역 질환의 경우 환자의 혈액에서 자가 면역 세포를 분리하고 유전자 발현 분석을 위해 DNA 또는 RNA를 추출하기 위해 세포 용해를 사용할 수 있습니다. 이 단계는 면역 세포에서 과발현되거나 발현되지 않는 특정 단백질과 유전자를 식별할 수 있어 질병의 진단과 맞춤형 의료 개발에 도움이 됩니다.
목차
제1장 세계의 세포 용해/세포 분획 시장의 도입
시장 개요
조사 범위
전제조건
제2장 주요 요약
제3장 VERIFIED MARKET RESEARCH의 조사 방법
데이터 마이닝
밸리데이션
1차 자료
데이터 소스 일람
제4장 세계의 세포 용해/세포 분획 시장 전망
개요
시장 역학
성장 촉진요인
억제요인
기회
Porter's Five Forces 모델
밸류체인 분석
제5장 세계의 세포 용해/세포 분획 시장 : 세포 유형별
개요
포유류 세포
미생물 세포
기타
제6장 세계의 세포 용해/세포 분획 시장 : 최종 사용자별
개요
연구기관 및 연구소
바이오 제약 및 바이오테크놀러지 기업
기타
제7장 세계의 세포 용해/세포 분획 시장 : 제품별
개요
기기
소니케이터
균질화
기타 장치
소모품
시약 및 키트
비즈
소모품
제8장 세계의 세포 용해/세포 분획 시장 :지역별
개요
북미
미국
캐나다
멕시코
유럽
독일
영국
프랑스
이탈리아
스페인
기타 유럽
아시아태평양
중국
일본
인도
기타 아시아태평양
라틴아메리카
브라질
아르헨티나
기타 라틴아메리카
중동 및 아프리카
아랍에미리트(UAE)
사우디아라비아
남아프리카
기타 중동 및 아프리카
제9장 세계의 세포 용해/세포 분획 시장 : 경쟁 구도
개요
기업별 시장 순위
주요 개발 전략
기업의 지역별 실적
기업의 산업별 실적
ACE 매트릭스
제10장 기업 프로파일
Thermo Fisher Scientific Inc.
Merck KGAA
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc.
Becton, Dickinson, and Company
Cell Signaling Technology, Inc.
Miltenyi Biotec
Roche Diagnostics
Qiagen NV
Qsonica, LLC
제11장 주요 발전
제품의 상시/개발
합병과 인수
사업 확대
파트너십과 제휴
제12장 부록
관련 조사
LSH
영문 목차
영문목차
Cell Lysis/Cell Fractionation Market Size And Forecast
Cell Lysis/Cell Fractionation Market size was valued at USD 4.55 Billion in 2023 and is calculated to reach USD 6.3 Billion by 2030, expanding at a CAGR of 7.2% from 2024 to 2030. The market's growth is attributed to the growing number of cultured cell procedures used for commercial diagnostic and analytical applications. The continued rise in the prevalence of various ailments and the demand for novel therapies are projected to drive market expansion throughout the forecast period. Additionally, the growing advances in cell biology research and increased demand for protein analysis due to the increasing prevalence of various chronic and non-chronic conditions are expected to positively influence the market's growth.
Global Cell Lysis/Cell Fractionation Market Definition
Cell lysis and fractionation are related techniques that have applications in cell biology to open and separate cells and their components. Cell lysis refers to breaking the cells open to release the components in the cell, such as nucleic acid, proteins, and cell organelles. The cell's opening is done chemically, mechanically, or enzymatically. Cell lysis is an essential step in several research applications, such as drug development, protein purification, and DNA isolation.
Cell fractionation refers to separating different components of the cell after lysis. The process is carried out through density gradient centrifugation, differential centrifugation, and other methods to isolate subcellular or specific organelles. The fractions of the obtained materials can then be used for further analysis.
What's inside a VMR industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Cell Lysis/Cell Fractionation Market Overview
The growing demand for personalized medicine among the population is a key driver for the market. Personalized medicine offers several advantages, such as tailored treatments, early disease detection, reduced healthcare costs, improved drug development, and more efficient clinical trials. Personalized medicines allow healthcare professionals to provide tailored treatment to patients. The treatment is based on lifestyle, specific genetic makeup, and other factors; these factors help to improve the treatment outcomes and reduce the risk of side effects of the drugs. Cell lysis has applications in personalized medicines for extracting and isolating specific molecules or cell types relevant to a patient's treatment and diagnosis.
Growing investments by public and private institutions for research in life sciences are anticipated to impact market growth positively. For instance, in March 2023, the UK government announced funding of GBP 277 Million, wherein the government will contribute GBP 17 Million. The remaining 260 million will be provided through private investments for life science manufacturing projects, minimizing environmental impact, boosting health resilience, and deploying innovations, contributing to the country's growth. The funding is anticipated to support the country's economy by providing more than 500 jobs nationwide.
Additionally, the increasing prevalence of chronic conditions such as cancer, diabetes, cardiovascular diseases, and arthritis, among others, is expected to impact the market growth positively. Cell lysis and fractionation are key steps used to diagnose chronic conditions. For example, diagnosis of autoimmune diseases such as rheumatoid arthritis and cell lysis can be used to isolate autoimmune cells from the patient's blood and extract the DNA or RNA for gene expression analysis. The step helps identify specific proteins and genes that are either over or under-expressed in the immune cells, helping diagnose the disease and develop personalized medicine.
Global Cell Lysis/Cell Fractionation Market: Segmentation Analysis
The Global Cell Lysis/Cell Fractionation Market is Segmented on the basis of Type Of Cell, End User, Product, and Geography.
Cell Lysis/Cell Fractionation Market, By Type Of Cell
Mammalian Cells
Microbial Cells
Others
Based on Type Of Cell, the market is bifurcated into Mammalian Cells, Microbial Cells, and Others. The mammalian cells segment accounted for the highest share in 2022 and is calculated to grow lucratively during the forecast period. The applications of these cells for the bio-manufacturing of vaccines, therapeutic proteins, and other recombinant products are key factors driving the segment's growth.
Cell Lysis/Cell Fractionation Market, By End User
Research Laboratories and Institutes
Biopharmaceutical and Biotechnology Companies
Others
Based on End User, the market is bifurcated into Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others. The Research Laboratories and Institutes segment held the largest market share in 2022 and is calculated to grow lucratively during the forecast period. The growing number of biotechnology institutes and many research activities undertaken by these institutes are driving the market's growth.
Cell Lysis/Cell Fractionation Market, By Product
Instruments
Sonicator
Homogenizers
Other Instruments
Consumables
Reagents and Kits
Beads
Disposables
Based on Product, the market is bifurcated into Instruments and Consumables. Instruments are classified into sonicators, homogenizers, and other instruments. Consumables are further differentiated into reagents & kits, beads, and disposables. The consumables segment accounted for the highest share in 2022 and is projected to grow lucratively during the forecast period. Repeated purchases, increased funding for cell-based research activities, and the increasing instances of chronic conditions among the population are factors driving the segment's growth.
Cell Lysis/Cell Fractionation Market, By Geography
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
On the basis of Regional Analysis, The Global Cell Lysis/Cell Fractionation Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America held the highest share in 2022 and is projected to grow lucratively during the forecast period owing to the technologically advanced R&D infrastructure. Moreover, the regional governments are also providing funding for the development of infrastructure and research projects, which is expected to impact market growth positively.
Key Players
The "Global Cell Lysis/Cell Fractionation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Thermo Fisher Scientific Inc., Merck KGAA, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Cell Signaling Technology, Inc., MiltenyiBiotec, Roche Diagnostics, Qiagen N.V., and Qsonica, LLC., among others.
This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.
Key Developments
In November 2022, Merck announced it would acquire Imago BioSciences Inc. The acquisition will help Merck to gain an edge over its competitors for clinical development.
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
Active, Cutting Edge, Emerging, and Innovators.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Cell Lysis/Cell Fractionation Market. We cover the major impacting factors driving the industry growth in the given region.
Porter's Five Forces
The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Cell Lysis/Cell Fractionation Market, gauge the attractiveness of a particular sector, and assess investment possibilities.
TABLE OF CONTENTS
1 INTRODUCTION OF THE GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porter's Five Force Model
4.4 Value Chain Analysis
5 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY TYPE OF CELL
6.1 Overview
6.2 Mammalian Cells
6.3 Microbial Cells
6.4 Others
6 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY END USER
7.1 Overview
7.2 Research Laboratories and Institutes
7.3 Biopharmaceutical and Biotechnology Companies
7.4 Others
7 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY PRODUCT
7.1 Overview
7.2 Instruments
7.2.1 Sonicator
7.2.2 Homogenizers
7.2.3 Other Instruments
7.3 Consumables
7.3.1 Reagents and Kits
7.3.2 Beads
7.3.3 Disposables
8 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 The U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 The U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Rest of LATAM
8.6 Middle East and Africa
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Rest of the Middle East and Africa
9 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET COMPETITIVE LANDSCAPE
